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Effect of Probiotics on Teething Problems in Infants/Toddlers 
 
Objective: To evaluate the potential effects of maternal/infant intake of 
probiotics on teething problems (TPs) in infants/toddlers. 
 
Methodology: In the GUSTO (Growing Up in Singapore Towards healthy 
Outcomes) cohort study 1237 pregnant women were recruited from early 
pregnancy and their offspring followed up. At ages 6, 9, 12, 15 and 18 months 
questionnaires were used to ascertain maternal/infant probiotics intake and the 
incidence rate of TPs.  
 
Results: The trend has been observed that infant intake of probiotics at 9 month 
or 3 week proved beneficial in reducing TPs at 15 month in infants. Maternal 
probiotics has shown detrimental effect on TPs in infants/toddlers. 
 
Conclusion: Timing and type of probiotics intake may affect teething problems, 
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Teething symptoms affects the infant during early years of life. Teething is a 
natural physiological phenomenon occurring in children and symptoms are 
mostly associated with primary dentition. Some of the most common signs of 
teething are increased salivation, rashes on face, gum rubbing, low grade fever, 
rubbing, increased finger sucking, loose stools, bleeding gums and 
inflammation. Present study focused on major teething symptoms such as 
teething fever, pain, decreased food intake and decreased daily activity . Out of 
these symptoms fever is objective whereas others are subjective. 
 
Probiotics bacteria are microorganisms that have beneficial effects on intestinal 
function and promote good health (Fuller, 1991). In the past few years, many 
researchers have focused on LAB (Lactic Acid Bacteria), in particular 
lactobacilli and bifidobacteria. Probiotics means ‘for life’ which is opposite to 
antibiotics ‘against life’. Probiotics are live bacteria, which are beneficial for 
human health and their activities may inhibit the growth of harmful bacteria 
which is opposite of antibiotics. 
 
The main objective of present study is to explore the association/effect of 
probiotics on teething problems in infants/toddlers. Data has been extracted 
from GUSTO (Growing Up in Singapore Towards healthy Outcomes) study to 
determine the effect of exposure (different time points) on outcome (different 











2 Literature Review 
2.1 Teething 
2.1.1 Teething Process 
 
Teeth  before eruption in oral cavity undergo three phases (Figure 2-1) (Hulland 
et al., 2000), first phase comprises of early tooth formation which involves 
enlargement of dental follicle until partial root development complete. During 
this phase there is minimal dental development but may have slight facial 
transposition in the alveolar bone (Fanning, 2008). In second phase, resorption 
of overlying tissues plays an important role which creates a path for eruption 
and also generates an eruptive force to move tooth vertically (Cahill and Marks, 
1980). Third phase concludes the post-emergent development involving the 
movement when the tooth erupts through gingiva until it reaches occlusal line 
with its opposite tooth (Haavikko, 1970).  
 
Deciduous tooth eruption is sometimes preceded by an eruption cyst of the 
overlying gum or by a smooth bluish swelling due to haematoma formation 
(Ashley, 2001a). 
 
Figure 2-1  Stages of eruption of maxillary incisor 
 
 
Fig. 2-3 (a) Pre-eruptive phase: Palpable- enlargement of 














Fig. 2-3 (b) Pre-eruptive phase: Emergent- gingival parting 
but incomplete incisal edge emergence of lateral incisor 
Fig. 2-3 (c) Eruptive phase: Partial eruption- the incisal edge 
is fully revealed but less than a quarter of the height is visible 







Reference:Modified by (Hulland et al., 2000) 
 
Teething process is regulated by genes, hormones, immunity and various other 
factors (AKL, 2010)as listed in Table 2-1. But, it is not clear whether these 
symptoms are co-incidental or directly associated with primary tooth eruption. 
Moreover, it is very difficult to assess reliably on infants expressions because 
they cannot explain or describe their distress explicitly.  There has been shown 
the association of teething pain, fever, decreased food intake and decreased 
daily activity with the first tooth eruption. Though pediatricians and dentists 
believe that few children suffered from TPs (Wake and Hesketh (2002) but still 
there are many pharmacological and non-pharmacological remedies present in 
market to reduce teething related clinical manifestations.  
Table 2-1 Regulatory factors involved in teething process 
Genes c-fos 
Hormones Pituitary growth hormone, thyroid hormones, parathyroid hormones 
Growth Factors Epidermal growth factor (EGF), colony-stimulating-factor-1 (CSF-1), 
transforming-growth-factors-β1 (TGF – β1) 
Cytokines Interleukin -1α (IL - 1α), interleukin - 1β (IL - 1β), interleukin -10 (IL – 10), 
tumor necrotizing factor – α (TNFα)   
Others Parathyroid hormone – related peptide (PTHrP), monocyte chemotactic protein 1 
(MCP – 1), immunoglobulin – A (IgA) 
Reference: Adapted from (AKL, 2010) 
Fig. 2-3 (d) Functional phase: Full eruption - a quarter or 
more of the crown of the incisor is visible above the surface of 
the gingiva of lateral incisor 
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2.1.2 Teething problems (TPs) 
 
Eruption of primary teeth is an important milestone for infants. Teething is a 
physiological process by which teeth erupts sequentially through gums. 
Similarly like colic disturbances and reflux, teething is an ill- defined infant 
problem which is misunderstood by parents due to non-scientific evidence 
(Wake et al., 1999).  
 
2.1.2.1 History of teething problems 
 
 Teething was known as ‘dentition defficilis’, Latin for pathologic dentition or 
difficult dentition. There is no acceptable theory till date regarding the 
occurrence of systemic problems during tooth eruption. But, it is believed that 
there is some link between nervous system stimulus and tooth eruption. 
Markman suggested a theory that the nervous system acted as link between the 
noxious stimulus of tooth eruption and systemic disease. It is fair to assume that 
infant’s nervous system  alters this fine balance, resulting in illness and death 
(Markman, 2009).  
 
There were some non-medicinal treatments to get rid of teething symptoms 
during 117AD (Ashley, 2001b). Physician Soranus of Ephesus suggested the use 
of hare’s brain to ease teething. In the sixth century AD, Aetios of Amida 
recommended that hare’s brain be given in the food either boiled or roast and if 
no hare could be found, a lamb’s brain would do just as well. In 1545, Thomas 
Phaire, an English physician, advised an ointment containing oil of roses and 
juice of nightshade. 
 
2.1.2.2 Use of Lancets 
 
Marshall Hall, (1790–1857) advocated the use of Lancets and stated that he 
‘would rather lance a child’s gums 199 times unnecessarily than omit it once if 
necessary’ and instructed his students to do it, before, during and after the teeth 
appeared, sometimes twice a day. By 1839, 5016 deaths in England and Wales 
were attributed to teething. The English Registrar-General report on teething of 
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1842 discussed infant mortality: 4.8% of all infants died in London under the 
age of 1, 7.3% of those between the ages of 1 and 3 and 12% of all deaths under 
four years were directly attributed to teething (L.Guthrie, 1908) .  
 
Medical Society of London in 1884, held a meeting on the subject of teething. 
Edmund Owen, Surgeon to the Hospital for Sick Children, stated that the lancet 
and the leech now ‘lie together in the same dark tomb’. Most colleagues at the 
meeting disagreed. Many believed that childhood ailments were caused by 
teething and had anecdotal evidence to support this. It was considered by most 
that failing to lance contributed to the high rate of infant mortality. In 1887, J. 
W. White wrote, ‘The nervous perturbation occasioned by the eruption of teeth 
increases the susceptibility and lessens the resistive power of the child’. It was 
believed that the difficulty experienced by an erupting tooth whilst penetrating 
gingival tissue affected trigeminal nerve endings. A ‘reflex stimulation’ of other 
cranial and spinal nerves ensued, producing ‘functional derangements’ and 
diseases in other organs. Lancing over an erupting tooth was recommended to 
allow bleeding and to release tissue pressure that was causing reflex stimulation 
of the trigeminal nerve. Any sick infant could be found to have an erupting 
tooth, even if the ‘tooth bud’ was deeply buried. This theory of reflex 
stimulation was reiterated as late as 1954 (James, 1954). 
 
2.1.2.3 Infant oral mutilation (Gidog) 
 
Gidog’ translated literally from Luo means “mouth-thing”, or “something for 
the mouth”. It is a belief that diarrhoea and fever are caused by ‘gidog’. ‘Gidog’ 
is believed to be a worm that comes beneath the gums, overlying the canines. 
Mothers who believe that ‘gidog’ exists take their children to a traditional healer 
when they develop diarrhoea or fever, who attempts to remove the ‘worm’ from 
beneath the gum surfaces. 
It is believed that if the white area on the gum bursts, and the child swallows 
the ‘worm’, then the child will die, and it is the perceived seriousness and strong 
belief in the problem that caused  parents to take their children for treatment 
(Bwenge, 1989).  
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2.1.2.4 Consequences of teething 
 
Early Utah pioneer records that begin in 1848 list teething as a relatively 
common cause of death. In the period 1847 to 1881, a total of 521 deaths were 
attributed to teething or related conditions. The number of cases listing teething 
as a cause of death increased gradually each year until 1866, when a precipitous 
jump occurred. The level remained relatively high for several more years 
Figure 2-2 (Gibbons and Hebdon, 1991).  
 
With increasing understanding of medicine and diseases came a gradual but 
recognizable change in the belief and practice of the dental profession. Also, the 
perspective of mothers’ and physicians to deal with teething symptoms has 
shown a drastic change. But, still there are mixed views for the treatment of 
TPs. Mothers use medicinal treatment, which is sometimes even more harmful 
than using lancets. Also, the coincidence of systemic symptoms during tooth 
eruption are mistaken and sometime overlooked under the impression that 
teething is always accompanied with systemic disturbances. One of the case 
study reported by P.H.R Wilson in 2002 (Wilson and Mason, 2002), a 10 month 
old baby was admitted to hospital in UK with a 2 week history of irritability, 
reduced feeding, shortness of breath and pyrexia. He already been diagnosed as 
‘teething’ and was prescribed an oral suspension of mefenamic acid (Ponstan®; 
50 mg/5 ml). An echocardiogram revealed a large secundum atrial septal defect 
(ASD) and mitral valve stenosis which got even worse with secondary 
congestive heart failure. After the surgery, condition of baby became stable. 
But, after 3 months during follow up visit, child presented with tender 
sublingual white patch. Also, his general health was deteriorating. After 
analysing the symptoms, doctors diagnosed oral candidiasis and prescribed 
fluconazole. Following this, after 2 weeks of fluconazole treatment, baby health 
got even worse. Finally, after discussing the history with parents it was revealed 
that Bonjela® (Reckitt and Colman, London, UK) (8·7% choline salicylate) was 
being used for ‘teething’ symptoms and was still ongoing. Medication was stop 
immediately and 1 week later child recovered completely. This case report is a 
combination of how the systemic manifestations are overlooked during tooth 




Figure 2-2 The number of diagnosed cases of "teething" as the cause of 
death in 19th century  
 
Reference: (Gibbons and Hebdon, 1991).  
 
2.1.2.5 Present perspective of teething problems 
 
However, emergence of teething oral cavity is not related to teething symptoms. 
Cytokines appear in the GCF of erupting primary tooth is correlated with some 
teething symptoms (Shapira et al., 2003). Teething problems like fever, pain, 
decreased daily activity and decreased food intake mostly occurs during tooth 
eruption in infants. A survey of teething beliefs and related practices among 
child healthcare workers in Ile-Ife, Nigeria demonstrates that majority of the 
dentists (79.3%) and pharmacists (96.2%) believed in teething problems. None 
of them based their belief on evidence-based scientific principles, but instead 
on personal experience (36.4%), books (26%), local myths (20.8%) and 
school/workshop (16.8%). Fever (18.2%) and diarrhoea (15.6%) were the most 
prevalent symptoms and signs believed to be associated with teething (Oziegbe 
et al., 2011). 
Swollen gums, drooling, irritability, inflamed gums, restlessness, sleeplessness 
and fever are major teething symptoms believed by the majority of parents in 
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IOWA (USA) (Barlow et al., 2002). Fever, irritability, increased salivation, loss 
of appetite and runny nose are some of the symptoms which were found 
significant during eruption of primary teeth (Jaber et al., 1992; Ramos-Jorge et 
al., 2011). Infants cut their teeth with fever is supported by Jaber in 1992, “The 
mean daily temperature was between 36.9C and 37.1C from day 19 to day 4 
before tooth eruption. Three days before the tooth eruption occurred the mean 
(SE) daily temperature increased to 37.14 (0.66) on day 3, 37.2 (0.68) on day 2, 
37.4 (0.76) on day 1, and reached its highest value of 37.6 (0.85) on the day the 
tooth erupted” (Figure 2-3) (Jaber et al., 1992) .A 8th  day window was defined 
as the teething period, increased biting, drooling, gum-rubbing, sucking, 
irritability, wakefulness, ear-rubbing, facial rash, decreased appetite for solid 
foods, and mild temperature elevation was found significant 4 days before a 
tooth emergence, the day of the emergence, and 3 days after the eruption of teeth 






















Figure 2-3 Mean daily temperature of children by day before eruption of 
first tooth 
 
Reference: (Jaber et al., 1992) 
 
However, another study found no significant correlation between fever and 
teething (Wake et al., 2000). According to Wake, tooth eruption in 
infants/toddlers is not associated with fever, mood disturbance, an appearance 
of illness, sleep disturbance, drooling, diarrhoea, strong urine smell, red cheeks 
and rashes on face and body which contradicts the findings of strong parent 
(Wake et al., 1999).   
 
A Survey conducted by Wake and Hesketh (2002), reported that professionals 
in all groups believed that parents experience even more distress than the infants 
themselves during teething. The main aim of the survey was to determine the 
current beliefs about teething in different professional groups in Victoria, 
Australia. Most of the participants thought that infants or young children suffer 









Figure 2-4 Percentage of each professional group reporting whether all or 
most, some, or few or no children have teething symptoms 
 
Reference: Wake and Hesketh (2002) 
 
Most health care workers agree that primary tooth eruption does not cause life-
threatening illness but there are other systemic difficulties regarding local and 
systemic symptoms (Wilson and Mason, 2002). Since teething believed to be 
always accompanied with systemic manifestation, for this reason other diseases 
occurring during tooth eruption are often overlooked. 
 
Literature on teething symptoms and opinions related to systemic symptoms in 
different groups was contradictory. The major reason may be that the 
information provided by parents is subjective in nature and it is difficult to 
distinguish between signs and symptoms. Also, the extended period of teething 
is a contributing factor for conflict in reports of various studies (Noor-






2.2 Potential effect of probiotics on teething problems 
 
There is no literature present regarding the effect of probiotics on teething 
problems in infants. It was assumed that LAB interacts with oral epithelium 
(Nermes et al., 2011). Nermes in 2011, investigate the interaction of L. 
rhamnosus GG with skin and gut microbiota and humoral immunity in infants 
with atopic dermatitis and reported that probiotics may enhance the gut barrier 
function and aid in development of immune responses in infants and 
commensals bacteria which can invade epithelial cells, stimulate IL-8 and TNF 
α secretion and correspondingly increased expression of IL-8 and TNFα 
(Toshifumi Ohkusa, 2008) (Karlsson et al., 2004; Mohamadzadeh et al., 2005). 
IL-1beta, TNF alpha, IL-8 are correlated with fever, sleep disturbances, GIT 
disturbances and appetite disturbances during teething in infants (Shapira et al., 
2003). It was reported that there was a significant difference in high levels of 
inflammatory cytokines during the teething period and control period (1 month 
after the eruption of tooth). 
  
2.2.1 Effect of maternal intake of probiotics on infants general health 
 
Maternal early dietary counselling and balanced nutrition is beneficial for the 
metabolic development of infant (Aaltonen et al., 2011). With some 
modification in dietary intake of fat and fiber and by the provision of appropriate 
food products combined with probiotics, we may not only improve the quality 
of the maternal diet (Piirainen et al., 2006), but also the maternal glucose 
metabolism up to 1 year after pregnancy (Laitinen et al., 2006). Study done 
byMyhre et al. (2011) suggested that milk products that contain probiotics might 
influence and reduce pregnancy complications, possibly through an effect of 
probiotics on vaginal tract infections and a reduction in overall inflammatory 
state. These findings suggests that probiotics has effect on systemic 
inflammation when taken by mothers’ during pregnancy but did not confirm 
whether this effect is transferred to infant or not. Knowing the fact that the 
dental follicle is a rich source of eicosanoids, cytokines and growth factors, it is 
plausible that teething may lead to local symptoms which are inflammatory or 
13 
 
irritative in nature (Wake et al., 2000). It may be hypothesize that effect of 
maternal probiotics in reducing inflammation helps to reduce inflammation 
during teething process. 
 
It should be noted that effect of maternal probiotics intake on teething is related 
to enhancement of immune system before birth (before pregnancy and one 
month before delivery) and immediately after birth (confinement period) 
whereas infant probiotics intake will have direct effect on infant. The immune 
modulatory effect of probiotics has been shown by  Pot et al. (2013) as listed 
below: 
 The innate immunity allows to rapidly and radically react towards 
challenges caused by infectious agents. The responses are inflammatory 
in nature and include mainly phagocytic cells (macrophages, 
neutrophils, natural killer cells). 
 The adaptive immune system, after activation by antigen-presenting 
cells, will mobilize specific T and B cells that will, through the 
production of specific signaling molecules (cytokines, chemokines), 
assist in the regulation of both the innate and adaptive immune 
responses. B cells secrete antibodies (providing humoral immunity), 
whereas T cells are subdivided into T helper cells (CD4+, also called 
Th) and T cytotoxic cells (CD8+). Since antigen presenting cells in the 
intestinal mucosa continuously sample intraluminal intestinal antigens, 
the central challenge of the gut immune system is to continuously 
balance defense with tolerance: choosing to activate effector T cells that 
enhance defense against pathogens, or promote differentiation into 
various regulatory T cell subsets that induce tolerance. The latter 
mechanisms have to protect the host from excessive inflammation 
during the course of an infection or help to rebalance the immune system 
when disturbed. The innate immune cells will therefore continuously 




2.3 Probiotics  
 
Probiotics are dietary supplements containing potentially beneficial bacteria. 
They are live microorganisms beneficial to the host organism and, when 
administered in adequate amounts, confer a health benefit on the host. Lactic 
acid bacteria and bifidobacteria are the most common types of microbes used as 
probiotics. Probiotics strengthen the immune system to combat allergies, stress, 
exposure to toxic substances and other diseases. It helps in stimulating oral 
health flora, and interferes with the pathologic colonization and disease spread. 
Probiotics can be bacteria, molds and yeast, but most probiotics are bacteria. In 
recent years, there has been a lot of interest in the use of probiotics in 
maintaining good oral health and treating oral infections. Their use in 





Probiotics were first introduced by Russian scientist and Nobel laureate Eli 
Metchnikoff, in the beginning of 20th century. He suggested that LAB can alter 
the activity of pathogenic bacteria in intestine. Most commonly studied 
probiotics are lactobacillus and bifidobacterium. ''Bifidobacteria'' were first 
isolated from a breast-fed infant by Henry Tissier (Guarner, 2008). The isolated 
bacterium named Bacillus bifidus communis was later renamed to the genus 
''Bifidobacterium''. 
 
After Metchnikoff’s death in 1916, the research on LAB moved to the United 
States. In 1935 certain strains of ''Lactobacillus acidophilus'' were found to be 
very active when implanted in the human digestive tract. Clinical trials proved 
lactobacillus effective against constipation and chronic diarrhea.  Contrasting 
antibiotics, probiotics were defined as microbial derived factors that stimulate 
the growth of other microorganisms. In 1989 Roy Fuller suggested a definition 
of probiotics which has been widely used, “A live microbial feed supplement 
which beneficially affects the host animal by improving its intestinal microbial 
balance” (Fuller, 1991). According to the German deﬁnition, probiotics are 
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deﬁned viable microorganisms, sufﬁcient amounts of which reach the intestine 
in an active state and thus exert positive health effects (Vrese and Schrezenmeir, 
2008). 
 
2.3.2 Effect of probiotics on caries 
 
Oral microflora is responsible for oral health and changes in the microflora 
plays an important role in increasing/decreasing the incidence of oral diseases. 
Oral disorders such as dental caries and periodontitis are considered to be the 
global burden of disease (Murray et al., 2012). Caries is one of the dental 
diseases which causes demineralization of hard tissues and destruction of the 
organic matter of the tooth by bacterial production of acids from the hydrolysis 
of the food debris accumulated on the tooth surface. Re-mineralization of tooth 
surfaces may occur in the presence of calcium, phosphates and fluorides. The 
capability of LAB to reduce the pH as low as 4 inhibits the further growth of 
S.mutans and dextran production (Russell and Ahmed, 1978). Short term intake 
of probiotics i.e. 1 week or 2 weeks didn’t show colonization of lactobacilli in 
oral cavity (Busscher et al., 1999). Studies done in past demonstrated that 
lactobacilli decreased S.mutans count in saliva, but this activity was time 
dependent. Supplementation of probiotics for 2 weeks was not sufficient for 
lactobacilli to colonize in oral cavity (Lexner et al., 2010). Table 2-2 and Table 
2-3 shows the summary of studies done in vivo and vitro to assess the effect of 











Table 2-2 Summary of RCT studies done in vivo to assess the effect of 
lactobacilli and bifidobacterium on S.mutans 
*, p ≤ 0.05; **, p ≤ 0.016       
    
Reference 
Sample size, Age, 
Design 
Vehicle, Time Species Oral Outcome 
Nase et al. 
(2001) 
594, 1-6years, DB Milk, 7 months L. rhamnosus GG  Decreased SMC* 
Ahola et al. 
(2002) 
74, 18-35 years, DB Cheese, 3 weeks L. rhamnosus     Decreased SMC* 
Montalto et 
al. (2004) 
35, 24-33 years, DB Liquid 45 days, 
Capsules 45 
days 
Lactobacillus spp. S. mutans count was not 
significantly modified 
and salivary counts of 
LB in saliva was 
increased** 
Nikawa et al. 
(2004) 
40, 20 years, DB Yoghurt, 2 
weeks 
L. reuteri    Decreased SMC* 
Caglar et al. 
(2005) 
26, 21-24 years, DB Yoghurt, 4 
weeks 
Bifidobacterium DN - 
173 010 
   Decreased SMC* 
Caglar et al. 
(2006) 
120, 21- 24 years,  
DB 
Straw, tablet 3 
weeks 
L. reuteri ATCC 55730    Decreased SMC with 
straw* and tablet*  
Caglar et al. 
(2007) 
80, 21 - 24 years chewing gum, 3 
weeks 
L. reuteri     Decreased SMC 
Caglar et al. 
(2008b) 




    Decreased SMC* 
Caglar et al. 
(2008a) 
20, 20 years, DB Lozenges, 10 
days 
L. reuteri ATCC      Decreased SMC* 
Lexner et al. 
(2010) 
18, adolescent, DB Milk, 2 weeks L.  rhamnosus LB21 No Effect 
Lodi et al. 
(2010) 






Lactobacillus sp. EPS was significantly 
lower in  Batavito® as 
compared to Yakult®  
® and sucrose* 
Singh et al. 
(2011) 
40, 12- 14 years, 
DB, crossover, 
placbeo 
Ice- cream, 10 
days 
B.lactis Bb12 
ATCC27536 and L. 
acidophilus La5 
    Decreased SMC* 
Jindal et al. 
(2011) 
150, 7-14 years, 
 
Powder, 14 days L.rhamnosus, 
Bifidobacterium sp. 
     Decreased SMC * 
Chuang et al. 
(2011) 
78, 20-26 years, DB Tablet , 2 weeks L.paracasei GMNL-33     Decreased SMC ** 
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Table 2-3 Summary of studies done in vitro to evaluate the effect of 
lactobacilli and their products on oral S.mutans 
≠, inhibits; *, p ≤ 0.05 
 
Probiotic therapy is of interest to treat caries as LAB are the natural inhabitants 
of oral cavity and considered as generally safe organisms with no side effects 
even if taken by new born infant (Chouraqui et al., 2008). Literature review 
revealed limited knowledge about the effect of probiotics on caries (Table 2-4)  
References Aim to Study/characterize Species/product Outcome 
O'Connor et 
al. (2006) 
To explore the inhibition activity of 
lacticin 3147 on  S.mutans 
lacticin 3147     Decreased SMC 
Yang et al. 
(2008) 
Probiotics characteristics of 
L.plantarum HO-69 applied in oral 
cavity 




To assess the interrelationship 





L.casei ≠ growth of S.mutans  
at pH 4 




To study the ability of daily 
applications of S. rattus JH145 to 
affect the numbers of an implanted S. 
mutans strain in rats model. 
S. rattus JH145    Decreased SMC 
Zahradnik et 
al. (2009) 
Preliminary assessment of safety 
and effectiveness of ProBiora3 a 
probiotics mouthwash 
S.oralis, S.uberis, 
lactic acid deficient 
variant of S.rattus 
     Decreased SMC 






stable and can be 
delivered in variety of 
vehicles 
L.paracasei DSMZ16671 has 
no affinity for 
hydroxyapatite. 
Coaggregation of S.mutans. 
Westbroek et 
al. (2010) 
Interaction of Lactobacilli with 
pthogenic S. pyogenes 
L. crispatus and L. 
jensenii 
Lactobacilli did not inhibit 
the growth of S.pyogenes and 
vice versa 
Wei et al. 
(2002) 
Effect of L.GG on immune product 
antibodies at ultra-high temperature 
and increase storage time 




Probiotics lactobacilli interfere with 
Streptococcus mutans biofilm 
formation in vitro 
Lactobacillus 
rhamnosus GG, L. 
plantarum 299v, and L. 
reuteri strains PTA 
5289 and SD2112 
L. reuteri SD2112 and L. 
rhamnosus GG strongly ≠ 
biofilm formation by 
S.mutans 
Keller et al. 
(2011) 
Co-aggregation and growth 
inhibition of probiotics Lactobacilli 











L. Plantarum strains showed 




Inhibitory effect of oral 
Lactobacillus against oral pathogens 
L.fermentum,L.salivari





lactobacillus showed a strong 




Table 2-4 Summary of studies done to characterize the effect of 
lactobacilli on caries 
*, p ≤ 0.05 
 
2.3.3 Risk & safety of probiotics 
 
Since clinicians are using probiotics as an adjunct or non-adjuvant therapy to 
eradicate systemic disorders their risk – to – benefit ratio may be important 
concern. Generally, lactobacilli are considered as safe, and only very  rare cases 
of local or systemic infections, including septicaemia and endocarditis caused 
by LAB have been reported (Adams and Marteau, 1995; Aguirre and Collins, 
1993; Gasser, 1994). Till date, no case of clinical infection by LAB has been 
reported (Adams and Marteau, 1995). Table 2-5 shows the summary of studies 















Species Oral Outcome 









    Decreased Caries                  
Stecksen-









    Decreased Caries* 
Tanzer et 
al. (2010) 
20, 21 day 







Inhibits the colonization of 
















2.3.4 Mechanism involved in oral cavity 
 
It is remarkable to know that lactobacillus although was known to be 
responsible for progression of caries can also be beneficial for oral health. Not 
all strains of lactobacilli are beneficial for oral health with only some strains of 
lactobacilli act against S.mutans. So far, LGG (Ahola et al., 2002; Aminabadi et 
al., 2011; Hatakka et al., 2007; Jindal et al., 2011; Nase et al., 2001; Yli-
Knuuttila et al., 2006), L. casei (Busscher et al., 1999; Russell and Ahmed, 
1978) L.reuteri (Caglar et al., 2006; Caglar et al., 2007; Caglar et al., 2008a; 
Nikawa et al., 2004),  Bifidobacterium DN - 173 010(Caglar et al., 2005), 
B.bifidum (Busscher et al., 1999), L.paracasei GMNL-33 (Chuang et al., 2011) 
and L.plantarum (Yang et al., 2008) were able to reduce or inhibit S.mutans’ 
activity. The exact mechanism of probiotics is still not clear. Figure 2-5 shows 





Table 2-5 Summary of studies done to assess the safety of probiotics 
Reference Study 
Design 
Age Group Disease Outcome 
Allen et al. (2010) 
 
RCT New Born Infant Acute Diarrhea Safe 
Aso and Akazan 
(1992) 
RCT Adults/Elderly Cancer Safe 
Beausoleil et al. 
(2007) 
 
RCT Adults/Elderly Hospitalized patients on 
antibiotics 
Safe 
Bravo et al. (2008) RCT Adults/Elderly Acute infectious disease Safe 
Chouraqui et al. 
(2008) 
 
RCT New born infant Healthy participants Safe 
Connolly et al. (2005) 
 
RCT Infant Family history of 
Allergy 
Safe 
Cui et al. (2004) 
 
RCT Adults Ulcerative colitis Safe 
Czaja et al. (2007) 
 
RCT Adults Recurrent urinary tract 
infections 
Safe 
L et al. (2006) RCT Adults/ Elderly Functional GI disorder 
 
Safe 




Ulcerative Colitis Safe 
Urbancsek et al. 
(2001) 
 





Safe denotes probiotics proved safe when supplemented to patients with different age 




Figure 2-5 Mechanism of probiotics in oral cavity 
 




Russell et al., 1978 found that when L. casei, L.fermentum and S.mutans mix 
together, pH drops to 4.5 and further drops to 4 in first 24 hours. The amount of 
plaque formed at acidic pH was lesser as compared to formed by streptococci 
at alkaline pH (Miller and Kleinman, 1974). This was further confirmed that the 
growth rate and sugar utilization by oral S.mutans decreases at an acidic pH , 
but different cariogenic strain of streptococcus  BHT and 2M2 grows optimally 
at pH 6.2 and 7.0 respectively (Figure 2-6) (Drucker, 1970; Komiyama, 1974). 
It is safe to assume that fall in pH as low as 4 may be the limiting factor for the 
growth of S. mutans and dextran production (Russell and Ahmed, 1978), 
whereas antimicrobial activity of LAB is more active at acidic pH rather than 




Figure 2-6 Rates of growth of different streptococcus strain at various pH 
values 
 




All probiotics lactobacilli showed an ability to co-aggregate with the isolated 
S.mutans strains. The selected lactobacilli inhibited S.mutans growth, but the 
ability varied between the strains and was clearly related to pH (Keller et al., 
2011). The specific co-aggregation of S.mutans by L. paracasei and L. 
rhamnosus strains specifically L. paracasei DSMZ16671, is interesting (Lang 
et al., 2010) but, other strains including L. paracasei and L. rhamnosus fail to 
co-aggregate with S. mutans (Lang et al., 2010).  One of the potential reason, 
may be because their ability to co-aggregate was heat stable, protease resistant 
moreover not affected by lactose, rhamnose or mannose  (Simoes et al., 2008)  
2.3.4.3 Inhibition by blocking adhesion sites 
 
L.acidophilus inhibits the attachment of pathogenic bacteria to Caco-2 cells in 
vitro (Ostad et al., 2009). The inhibition pattern was similar for live and heat-
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inactivated L. acidophilus (p < 0.01). The number of attached pathogenic 
bacteria to the Caco-2 cells decreased when the number of L. acidophilus 
increased from 106 to 109 CFU/ml. The heat-inactivated L. acidophilus 




Bacteriocins are defined as small antimicrobial proteins or peptides which are 
ribosomally synthesized by LAB into the growth medium. Its production by 
LAB is basically a cell survival mechanism which exhibits broad spectrum of 
inhibitory activity toward the closely related bacteria due to the combined action 
of bacteriocins and the autolysin (Gollop et al., 2003).  
 
Some probiotic strains may inhibit growth or adhesion of pathogenic bacteria 
by secreted products and not merely an effect of acidic pH (Kanmani et al., 
2013b). Bacteriocins exhibit antimicrobial activity either by inhibiting cell wall 
formation or causing pores in cell membrane and finally results in cytoplasm 
leakage and death of target bacterial strains (Cleveland et al., 2001; Deegan et 
al., 2006). Sookkhee et al. 2001 detected bacteriocins production by LAB using 
the method described by Mortvedt and Nes (1990). The supernatant fluids were 
made from the cultures grown in Lactobacillus de Mann – Rogosa – Sharpe 
broth (LMB; Difco) at 370 C under CO2 for 48h adjusted to pH 7.0 and treated 
with catalase. The treated supernatant fluid were twofold serially diluted and 
placed in the 96 well, flat bottom microtitre plate. Afterwards, S.mutans DTMU 
1 and C. albicans DTMU 2 were added.  One bacteriocins unit (BU ml±1) was 
defined as the reciprocal of the highest dilution, which inhibited 50% of the 
growth of S.mutans and C.albicans 
 
2.3.4.5 Secretion of Salivary IgA 
 
Oral intake of Lactobacillus pentosus strain b240 accelerates salivary 
immunoglobulin A secretion (Kotani et al., 2010) which in turn inhibits the 
activity of S. mutans and prevents its colonization (Hajishengallis et al., 1992).  
23 
 
Neuraminidase prepared from S.mitis ATCC 9811 was inhibited by salivary 
IgA. Therefore, it was considered that salivary IgA may inhibit other bacterial 
enzymes and toxins (Fukui et al., 1973). 
 
2.3.4.6 Criteria of selection for probiotics in oral cavity  
2.3.4.6.1 Adhesion 
 
Adhesion is considered of major importance which affects the competence of 
probiotics. The capacity of probiotics to adhere to surfaces of the oral cavity can 
avoid or at least reduce rapid exclusion from the environment. In the mouth 
adhesion is a necessary phenomenon in the microbe saliva interactions. 
Additionally, pellicle covering both mouth mucosa and dental hard tissues 
should be regarded as a mediator influencing adhesion. In vitro studies have 
assessed adhesion by measuring the attachment of bacteria to saliva-coated 
hydroxyapatite (HA) and oral epithelium (Stamatova et al., 2009) HA beads or 
discs serve as a surface sharing chemical and structural similarity to tooth 
enamel.   Probiotics and putative probiotics strains have been shown to vary 
extensively in their adhesiveness to saliva-coated HA. Among probiotics strains 
L. rhamnosus GG exhibited the highest values of adhesion, comparable to those 
of the early tooth colonizer S. sanguinis. Dairy starter L. bulgaricus strains 
adhered poorly to sHA (Stamatova et al., 2009). The adhesion of probiotics 
bacteria to oral soft tissues is another aspect that promotes their health effect to 
the host. Cell adhesion is a complex process involving contact between the 
bacterial cell and interacting surfaces. The epithelial lining of the oral cavity 
despite its function as a physical barrier, actively participates in immune 
response. It has been shown that oral administration of probiotics bacteria may 
stimulate local immunity and modulate the inflammatory response (Chapat et 
al., 2004; Meydani and Ha, 2000). 
It is important to understand  the ability of probiotics to adhere to the epithelium 
cells and to produce inhibitory substances against pathogenic bacteria 
(Nemcova, 1997). Adhesion of lactobacilli to the gastrointestinal tract is a factor 
affecting the capacity of lactobacilli to persist within the gastrointestinal tract 
and to act as an adjuvant for orally administered antigen (Plant and Conway, 
2002). Different LAB strains exhibits different adhesion properties for example, 
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L.acidophilus strains adhered more often to buccal epithelium (2.58-4.60) and 
rarely to intestinal and vaginal. L. plantarum manifested high adhesive activity 
(8.03 -9.69) to buccal epithelium (Kovalenko et al., 2004) and there are few 
studies which have shown the varied adhesion property of different lactobacillus 































Table 2-6 Summary of studies investigating the adhesion properties of 
lactobacilli in oral cavity. 
*p < 0.05 
 
Reference Aims of the study Species Outcome 
 
Busscher et al. 
(1999) 
In vitro adhesion to enamel 
and in vivo colonization of 
tooth surfaces by 




Adhesion of L. 
acidophilus is much 
stronger than L. casei. 
Lima et al. 
(2005) 
To compare the adhesion of 
L.casei shirota and L. 
acidophilus to an artificial 
caries model 
L. casei shirota, L. 
acidophilus 
Inferior adhesion of L. 
casei shirota as compared 
L. acidophilus 
Stamatova et al. 
(2009) 
In vitro evaluation of 
yoghurt starter lactobacilli 
and L.GG adhesion to 
saliva-coated surfaces 
L. delbrueckii subsp. 
bulgaricus strains 
and L. rhamnosus 
GG 
 Adhesion of the L. 
delbrueckii subsp. 
bulgaricus strains 
remained lower in 
comparison to L. GG. 




probiotics strains for 
improving oral health 
S.salivarius,L.reuteri 
,AB1 to AB46 
LAB exhibits 
antimicrobial activity 
against oral pathogens, 
ability to aggregate and to 
adhere to oral tissues or 







 To assess the ability of 
biofilm formation among 
mutans and non-oral S. 
mutans and to determine the 
effect of L. acidophilus 
DSM 20079 on the 
adhesion of streptococcal 
strains  
L. acidophilus DSM 
20079 
The L. acidophilus had 
more effect on adherence 
of  S. mutans than non  S. 
mutans significantly * 
Samot et al. 
(2011) 
Adherence capacities of 












 The classic criterion for a successful probiotics agent is the ability of 
microorganism to colonize in intestine and oral cavity (Michail, 2005). 
Supplementation of L.reuteri ATCC 55730 regularly for 28 days showed 
significant colonization of the stomach, duodenum, and ileum of healthy 
humans, and this is associated with significant alterations of the immune 
response in the gastrointestinal mucosa (Valeur et al., 2004). Probiotics intake 
for less than 3 weeks proved to be insufficient for permanent colonization of 
L.reuteri ATCC 55730 in oral cavity (Caglar et al., 2009). Fermented milk 
containing L.paracasei when consumed twice daily for 12 weeks, was isolated 
8 weeks after the end of the administration period from the faecal samples of 
individuals (Åsa Sullivan et al., 2002). To inhibit the activity of pathogens in 
intestine and oral cavity, probiotics should have the ability to colonize. Table 
2-7 shows the summary of studies assessing the colonization of probiotics in 
oral cavity. 
 
Table 2-7 Studies done to illustrate the colonization of probiotics in oral 
cavity  












Busscher et al. 
(1999) 
In vitro adhesion to enamel and 
in vivo colonization of tooth 




Lactobacilli fail to 
colonize oral cavity after 
one week consumption of 
bio - yoghurt 
Tanzer et al. 
(2010) 
Caries inhibition by and safety 
of L.paracasei DSMZ16671 
L.paracasei 
DSMZ16671 
Inhibits the colonization 
of S. mutans 
Aminabadi et al. 
(2011) 
Effect of chlorhexidine 
pretreatment on the stability of 
salivary lactobacilli probiotics in 
six- to twelve-year-old children: 
a randomized controlled trial 
L.rhamnosus 
GG 
Increased colonization of 








The effect(s) of probiotics on teething problems has not been studied till date. 
Search criteria from popular databases namely Pubmed, Web of Science, 
Science Direct, JSTOR and WebMd found no published data related to effect 
of probiotics on teething problems in infants with the following  keywords: 
probiotics, teething; L.casei, teething; lactobacillus during teething; primary 
teeth, lactobacillus. Probiotics have shown positive effects in reduction of 
caries, periodontitis/gingivitis but so far no study has explored its effect on 
teething problems. 
Aim/Objective and specific hypothesis: 
Objectives 
 To assess the effect(s) of maternal intake of probiotics during prenatal, 
perinatal and postnatal (confinement period) period on TPs in 
infants/toddlers. 
  To characterize the effect(s) of child’s intake of probiotics during 3 















There is no literature regarding the effect of probiotics on teething problems. 
But, TPs is one of the most common physiological phenomenon which occurs 
before tooth erupts in oral cavity and most of times is irritating to 
infants/toddlers. The main objective of present study is to explore the 





















3 Materials and Methods 
3.1 Introduction to GUSTO Cohort  
 
GUSTO cohort is presently Singapore’s largest and most comprehensive birth 
cohort. The recruitment of subjects commenced in 2009, at 2 major public 
maternity hospitals (National University Hospital and KK Women’s and 
Children’s Hospital).  Mothers were followed throughout their pregnancy and 
their offspring will be seen until the child reaches 4 years of age. The primary 
objective of the GUSTO birth cohort study is to evaluate the role of 
developmental factors in the early pathways to metabolic compromise, namely 
obesity and type 2 diabetes mellitus. The intention of being a holistic cohort 
study with a   multidisciplinary approach, GUSTO is further subdivided into 
several secondary domains (Figure 3-1) with individual objectives to maximize 
the research opportunities that have arisen. Oral health is a sub-domain of 
GUSTO cohort 
 














3.2 Ethical Considerations 
3.2.1 Ethical Approval 
 
IRB (Institutional Review Board) approval for NUS (National University of 
Singapore) and DSIRB approval for KKH site were granted before the 
commencement of study at both the sites. 
 
3.2.2 Participant Information sheet (PIS) 
 
The approved PIS includes study information, PI contact details and purpose of 
research study. After reading this information, participant get a brief idea about 
the procedures followed in study and their responsibilities to make this project 
efficient and useful for research. To ensure the satisfaction of participant 
information was translated in their own language. Consent was given by each 
participant knowing that their participation is voluntary and can stop 
participating at any time. 
 
3.3 Recruitment of subjects 
3.3.1 The study population 
 
Study population consist of all pregnant women attending the first trimester 
antenatal dating ultrasound scan clinic at the 2 major government hospitals 
(NUH and KKH) who are Singapore citizens or Singapore permanent residents 
and who currently reside within a 15 km. radius of NUH or KKH. Women 
intended to eventually deliver in NUH or KKH and to reside in Singapore for 
the next 5 years were included. From the pilot survey, 94% of women at the 
antenatal clinics said that they were likely to deliver in the same hospital while 
86% intended to stay in Singapore for next 5 years. Women who live closer to 
the 2 hospitals were included to facilitate the travel of interviewers to and 
between the subject’s homes. Only women who agreed to donate cord, cord 
blood and placenta at delivery were included. IVF singleton pregnancies and 
women with bad obstetric histories were also recruited. Both private and 
subsidized patients were enrolled. Women whose pregnancies end in 
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miscarriages were excluded later and counseled. Figure 3-2, shows the strategy, 
recruitment and progress made so for in GUSTO cohort. 
 
Figure 3-2 Progress of GUSTO cohort 
 
Reference: (Soh et al., 2013) 
 
3.3.2 Recruitment strategy 
 
The recruitment phase was initiated by engaging the co-operation of all 
obstetricians, pediatricians and the public through a variety of approaches 
including talks, media, recruitment brochures and posters.  
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3.3.3 Informed consent form 
 
Informed written consent was obtained from each participant either on the day 
of the study staff first approach the subject or a few days later if she prefers to 
consult her spouse. From the pilot study, 62% of women would like to discuss 
participation with their spouse before making a decision. Dedicated, trained 
staff explained the nature of the study, including benefits and risks, and 
confidentiality of the data. 
 
3.4 Research Design 
 
GUSTO is a long-term cohort study with sample size of 1237 subjects involving 
Singaporean mothers-to-be aimed at discovering effective prevention and early 
intervention strategies to reduce the burden of metabolic diseases, including 
Obesity and Type 2 Diabetes Mellitus. GUSTO is the centerpiece of the 
“Developmental Origins: Singapore” program which was awarded the S$25 
million Translational and Clinical Research Flagship Grant by the National 
Research Foundation. According to Prof. Kenneth Kwek from KKH, “The 
research team hopes to discover effective prevention and early intervention 
strategies, which may be in the form of simple lifestyles, nutritional intervention 
or preventive drugs to reduce the burden of metabolic diseases.” Following are 
the main aims of GUSTO birth cohort: 
 Improve the health of Singapore and sharing this with the global 
community 
 Develop  better drugs, devices, and predictive tests for our patients 
 Develop health services research to answer issues of cost and 
effectiveness 
 Focus on Asia  
Oral health is one of the sub-domains working with GUSTO to explore the risk 
factors related to various oral health manifestations. To accomplish the aims and 
objectives of the present study the questionnaires were asked to 
mothers/guardian at different time points. These questionnaires were 
interviewed by trained home visitors and were given to clinic staff nurses. 
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Separate database (LORIS) is maintained and to secure the confidential data 
every individual has his own ID and password.   
3.5 Data collection 
 
Maternal and infant information was collected at different time points (Figure 
3-3). Data has been collected by trained nurses and trained home visitors. 
Standardization of data collection was maintained at all phases to avoid 
discrepancies at various stages. Staff were calibrated to ask specifically about 
the symptoms occurring during tooth eruption so that they can easily explain 
parents and avoid confusion between systemic symptoms and teething 
symptoms. To ensure the capability of staff, periodic training was given by 
research coordinator before they finally step into main questionnaire survey. 
 






3.5.1 Collection of maternal data 
 
Detailed one - hour interviews were conducted at the women homes during the 
second (16 weeks) and third trimester (33 weeks). A 159 item food frequency 































dietary recall developed for use in the SCCS based on the Singapore national 
food composition database assessed maternal nutrition at 16 and 33 weeks.  
 
Maternal dietary patterns during the confinement period (which has unique 
Asian characteristics) was determined three weeks after delivery. Traditional 
cultures and influences still play a significant role in affecting lifestyles of 
Chinese, Malays and Indians. Women typically change their diets, refrain from 
leaving the house and consume traditional herbs or tonics.  
 
 
3.5.2 Collection of infant data 
 
During infancy, home visits conducted at 3 weeks, 3, 6, 9, 12, 15, 18, 24 and 36 
months. Infant breastfeeding pattern including duration, partial versus total 
breastfeeding and expressed versus direct breast milk was elicited to analyze 
specific effects on outcomes. Infant diet after weaning was captured using 3-
day food diaries with portion size guides customized for this age group. 
Development milestones, physical activity and health status were elicited via 
interviews.  
 
3.5.3 Collection of infants’ oral health data 
 
Collection of oral health data was divided into 2 phases as shown in Figure 3-
4. Till 24 months information was gathered by trained home visitors and clinic 
staff regarding number of teeth erupted and teething problems occurred during 
the tooth eruption. This information was taken by face to face questionnaire 
survey with mothers/guardian. To capture most possible accurate data for TPs, 
home visitors were trained to ask mothers’ specifically about the 
problems/symptoms occurring/occurred at the time of first tooth eruption. This 







Figure 3-4 Schematic representation for the collection of oral health data 
 
 
3.6 Dealing with missing data 
 
Missing data is the most common issue for epidemiologic studies. The attrition 
rate in GUSTO was 12% per year. There are chances that subjects may miss 
home visit/clinic visit. In the present study, missing data was excluded while 
doing data analysis. 
 
3.7 Follow–up of participants 
 
The cohort was designed to maximize recruitment and retention using a model 
that included a combination of regular home visits and the collection and 
addition of tests at regular antenatal visits at the two hospitals. This was done to 
decrease the possibility of missing visits, increase contact with other family 
members including the father and grandparents, and ultimately increase the 
follow-up rate. The visits were scheduled at a date and time convenient for the 
participants, and included evening and weekend visits.  
 
It was expected that 10 nurses were able to visit approximately 1000 homes 
every 6 months during the most intensive phase of the study. The use of multiple 
strategies reduced lost-to-follow up bias. All efforts were made to increase the 
Oral Health












follow up of the mother – child pairs and decrease the number of missing visits. 
Repeated reminder calls and reminder cards were posted to the subjects homes 
prior to each home visit and cash reimbursements were given at each visit. 
Furthermore, constant communication and contact with the participants were 
maintained by setting up a study website, 6 monthly newsletters were sent to 
the participants and New Year cards were posted to all participating families.  
 
3.8 Data Entry and cleaning 
 
Data cleaning and data entry was divided into 2 phases (first and second data 
entry) in which data was cleaned and then entered by 2 different well qualified 
data administrators at 2 times to ensure internal validity of data. To ensure the 
internal data validation infant and maternal probiotics data was checked twice 
by different persons. Separate database known as LORIS was maintained by 
data team manager and only data coordinators/domain members have the access 
to this software. To maintain the confidentiality of data each data coordinator 
has their own login and password details assigned by data manager. 
 
3.9 Data analysis 
 
The software used for data analysis was SPSS, data analysis framework for enter 
model and Poisson Regression as shown in Table 3-1, was used for dependent, 

























Confounding Variables  
(CV) 
Interactions 















problems (TPs) time 
points:  
 6 month 
 9 month 
 12 month 
 15 month 





























IV2. Infant probiotics 
intake time points: 
 3 week 
 3month 
 6 month 
  9 month 
 12 month 
 15 month 
 
 
CV1. Mother breastfeeding status 
 Yes 
 No 
CV2. Household Income level 
 < 4000S$ 
 ≥ 4000S$ 
CV3. Mother’s long-term illness 
 Yes 
 No 
CV4. Mode of delivery 
 Normal vaginal 
 C-section 
CV5. Age of mother 
CV6. Education level 
 Non-tertiary 
 Tertiary 







CV9. Child’s health  
 Fever 
 Diarrhoea 






1.Interaction within maternal 
source of probiotics: 
 Yakult®  ® 
 Vitagen®  ® 
 Yoghurt 
 Yoghurt drinks 
 Supplements 
 
One month before delivery & 
Confinement Period 
2. Interaction within infant 
source of probiotics: 






3 week up to 15 months 
3. Interaction between 
maternal and infant probiotics 
intake: 
 Yakult®  ® 
 Vitagen®  ® 
 Yoghurt 
 Yoghurt drinks 
 Maternal 
supplements 
 Formula milk 
 Infant yoghurt 
 Infant supplements 




4.1 Demographic and socio-economic profile of GUSTO cohort 
study 
 
Half of the population in GUSTO birth cohort study is Chinese (55.8%) Malay 
(26.2%) and Indians (18.0%). With regards to household income population is 
equally distributed among the middle and high income categories as shown in 
Table 4-1. 
Table 4-1 Frequency of subjects by race, infant gender, maternal 







Factors N (%) Total (N) 
Ethnicity Chinese 690 (55.8%) 1237 
Malay 324 (26.2%) 
Indian 223 (18.0%) 
Gender Male 617 (52.8%) 1169 
Female 552 (47.2%) 
Education No education/primary 56 (4.6%) 1220 
Secondary 449 (36.8%) 
University 715 (58.6%) 
Household 
income 
0 – 999S$ 32 (2.8%) 1152 
1000 – 1999S$ 151 (13.1%) 
2000 – 3999S$ 349 (30.3%) 
4000 – 5999S$ 289 (25.1%) 
≥ 6000S$ 331 (28.7%) 
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4.2 Teething Problems 
4.2.1 Distribution of teething problems on the basis of frequency at 
different time points 
 
The information about the incidence of TPs was taken at month 6, 9, 12, 15 and 
18. In the present study, there are 4 major outcomes namely teething pain, 
teething fever, decreased food intake and decreased daily activity. The 
frequency of TPs differs at various time points as shown in Table 4-2. 
 
Table 4-2 Frequency of teething problems on the basis of frequency at 









































 Note: Remaining subjects are either missing, not answered or not applicable                 
 
4.2.2 Incidence of overall TPs at different time points  
 
In the present study it was observed that infants experienced more TPs at 18 






Figure 4-1 Schematic representation to show incidence of overall TPs at 
different time points from 6 month to 18 month  
 
4.3 Probiotics intake 
4.3.1 Maternal probiotics intake 
4.3.1.1 Maternal probiotics intake of different source of probiotics at 
different time points 
 
Maternal probiotics intake were from 5 different sources namely yoghurt, 
Vitagen®, Yakult®, other yoghurt drinks and supplements taken before 
pregnancy, one month before delivery and during confinement period (Table 4-
3). 
Table 4-3 Frequency of maternal probiotics intake of different sources of 
probiotics at different time points 
Time points Yoghurt  
 N(%) 
Vitagen®   
 N(%) 










NA NA NA NA 222 (18.2%) 
One month 
before delivery 
174 (17.3%) 70 (7.0%) 115(11.5%) 29 (2.07%) 26 (2.5%) 
During 
confinement 
74 (7.3%) 36 (3.5%) 65 (6.4%) 17 (1.65%) 17 (1.6%) 






6 MONTH 9 MONTH 12 MONTH 15 MONTH 18 MONTH
Overall TPs at different time point
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4.3.2 Infant probiotics intake 
4.3.2.1 Infant formula milk intake according to prebiotics, probiotics 
and synbiotics 
 
Infant probiotics intake were from 3 different sources i.e. formula milk, yoghurt 
and supplements. Different formula milk brands contain prebiotics, probiotics 
or synbiotics as shown in Table 4-4. For this reason, formula milk was further 
divided into prebiotics, probiotics or synbiotics depending upon the ingredients 
of the brand consumed by infants at different time points. Data related to 
yoghurt intake was collected at 9 month and 12 month only as a part of weaning 
diet. 
Table 4-4 Frequency of infant intake of prebiotics, probiotics, synbiotics, 
supplements and yoghurt at different time points 















 N (%) 
Yoghurt 
 N (%) 











98 (13.1%) 135 
(18.1%) 





98 (12.7%) 253 
(32.7%) 

























97 (11.0%) 372 
(42.1%) 





83 (9.8%) 343 
(40.4%) 
58 (6.3%) NA 
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4.4 Potential confounders 
4.4.1 Breastfeeding practice 
 
Breastfeeding practice is one of the major potential confounder of the present 
study. It has been noticed that during first 3 week after the birth majority of 
mothers’ initiated breastfeeding and then slowly declines until 18 months. 
Table 4-5 Frequency distribution of breastfeeding practice at different 
time points 
Time points                           Frequency (%) 
Week 3 92.1 
Month 3 55.5 
Month 6 39.8 
Month 9 28.3 
Month 12 21.7 
Month 15 14.5 
Month 18 10.8 
 
 
4.4.2 Association between maternal factors and TPs 
 
Significant (p = < 0.001) association between breastfeeding at month 9 (p = 
0.01) and breastfeeding at M12 (p = 0.01) with TPs was reported. But, no 
significant association was found between mother long term illness (p = 0.50), 
mode of delivery (p = 0.93), maternal smoking status during pregnancy (p = 
0.56) with cumulative TPs.  
 
4.4.3 Association between child factors and TPs 
 
Child health factors has shown significant association with the cumulative 
overall TPs. Diarrhea at month 3 (p = 0.004) and month 18 (p = 0.04), fever at 
month 9 (p < 0.001), month 12 (p = 0.03), month 15 (p = 0.02) and month 18 
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(p = 0.02) also antibiotics at month 15 (p = 0.001) were found significantly 
associated with TPs.  
 
4.5 Inferential data from the multivariate regression  
4.5.1 Effect of maternal and probiotics intake on TPs 
 
Different data analysis approaches were explored to achieve maximum 
accuracy and meaningful results. First, an enter model was followed which 
included all confounders, dependent, independent variables and interactions 
between maternal and infants probiotic sources and also within the maternal and 
infant probiotics. The enter model (with logistic regression) revealed the trend 
but with very wide 95% CI and OR. Then, the same framework was followed 
for Poisson Regression to confirm the results and trend. Findings which were 
congruent or convergent in both the analysis are shown in Table 4-6. 









risk [RR]; 95% CI) 
Concurrent 
findings of enter 
and Poisson model 
Maternal 
yoghurt intake 
One month before delivery 
Increased decreased 
food intake M9 
([1.009]; 1.002 - 
1.017) 
During confinement 
Increased overall TPs 





One month before delivery 
Increased teething 
fever M18 ([1.018]; 




3 week  
Decreased increased 
teething pain M15 
([0.877]; 0.781 - 
0.984) 
Increased decreased 
food intake M18 
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([1.413]; 1.175 - 
1.699) 
6 month  
Increased teething 
fever M12 ([1.294]; 
1.079 - 1.552) 
Increased overall TPs 
M12 ([3.642]; 1.549 
- 8.564) 
9 month  
Decreased teething 
pain M15 ([0.760]; 




3 week  
Increased teething 
fever M18 ([1.445]; 
1.091 - 1.913) 
Increased decreased 
food intake M18 




fever M12 ([1.464]; 
1.090 - 1.966) 
9 month 
Decreased decreased 
food intake M15 
([0.592]; 0.466 - 
0.753) 
Decreased overall 
TPs M15 ([0.203]; 
0.053 - 0.780) 
12 month  
Increased decreased 
food intake M15 
([1.552]; 1.182 - 
2.038) 
Increased teething 









TPs M15 ([0.467]; 
0.255 - 0.857) 
Increased decreased 
food intake M18 








pain M15 ([1.275]; 
1.125 - 1.446) 
Increased overall TPs 
M15 ([3.189]; 1.677- 
6.063) 
6 month  
Increased teething 
fever M12 ([1.210]; 
1.010 - 1.451) 
Increased overall TPs 
M12 ([3.278]; 1.388 
- 7.742) 
9 month  
Decreased teething 
pain M15([0.721]; 
0.595 - 0.873) 
Note: Shaded portion represents the positive association 
 
The major trend observed in Table 4-6 is the negative effect of maternal and 
infant probiotics intake. The beneficial effect of infant probiotics or synbiotics 
intake appeared at week 3 and 9 month in reduction of the incidence of teething 
pain or overall TPs at M15. The positive association between probiotics and TPs 
was found if taken at 9 month. 
4.5.2 Effect of potential confounders on TPs 
 
In the present study, 10 potential confounders were taken into consideration 
namely; breastfeeding practice, gender, race, mother age, household income, 
child health (systemic fever, diarrhea or child antibiotics) long term illness, 
mode of delivery, education level and mother smoking status during pregnancy. 







Table 4-7 Result summary of effect of breastfeeding practice on TPs 
Independent variable 
(Confounder) 
Time points Outcome ([RR]; 95% CI) 
Breastfeeding practice Week 3 Increased decreased activity 
M9 ([1.072]; 1.013 – 1.134) 
Increased decreased food 
intake M15 ([1.152]; 1.010 – 
1.313) 
Month 3 Decreased teething fever 
M15 ([0.844]; 0.761 – 
0.935) 
Decreased overall TPs M15 
([0.558]; 0.342 – 0.912) 
Month 6 Increased decreased activity 
M9 ([1.066]; 1.004 – 1.132) 
Month 9 Decreased teething pain 
M12 ([0.828]; 0.713 – 
0.962) 
Decreased teething fever 
M12 ([0.787]; 0.664 – 
0.934) 
Decreased decreased activity 
M12 ([0.869]; 0.771 – 
0.980) 
Month 12 Increased overall TPs M18 
([4.033]; 1.009 – 16.123) 
Month 15 Nothing significant 
Month 18 Nothing significant 
Note: Shaded portion represents the positive association  
 
According to the findings of Table 4-7, breastfeeding practice at month 3 has 
shown positive effect on the outcome at M15 teething fever and overall TPs 
whereas breastfeeding practice at month 9 has shown positive association to 
reduce the incidence of teething pain, teething fever and teething related 
decreased activity at M12. 
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The effect of other potential confounders on TPs is listed in Table 4-8. 
 














Chinese  Increased decreased food intake M9 
([1.234]; 1.115 – 1.365) 
Increased decreased food intake M15 
([1.136]; 1.031 – 1.251) 
Increased teething pain M18 ([1.283]; 




Increased teething fever M15 ([1.166]; 
1.030 – 1.320) 
Increased teething pain M18 ([1.199]; 
1.011 – 1.421) 
Increased teething fever M18 ([1.259]; 
1.019 – 1.556) 
Mother age 
(continuous) 
NA Decreased teething fever M9 ([0.990]; 
0.983 – 0.998) 
Decreased decreased food intake M9 
([0.991]; 0.984 – 0.998) 
Decreased overall TPs M9 ([0.964]; 
0.930 – 0.998) 
Decreased decreased food intake M12 
([0.987]; 0.979 – 0.996) 
Decreased overall TPs M12 ([0.948]; 
0.913 – 0.985) 
Increased decreased food intake 
















Month3  Nothing significant  
Month 6  Increased decreased food 
intake M15 ([1.290]; 1.155 
– 1.441) 
Month 9  Nothing significant  
Month 12  Decreased decreased food 
intake M18 ([0.828]; 0.711 
– 0.965) 
Month 15  Decreased teething pain 
M18 ([0.851]; 0.747 – 
0.969) 
Systemic fever Month 3 Increased overall TPs M15 
([2.187]; 1.313 – 3.644) 
Decreased teething fever 
M18 ([0.828]; 0.703 – 
0.976) 
Month 6  Nothing significant 
Month 9  Increased overall TPs M15 
([1.567]; 1.104 – 2.222) 
Month 12  Decreased overall TPs M15 
([0.598]; 0.402 – 0.889) 
Month 15  Nothing significant 
Antibiotics Month 3 Decreased teething fever 
M15 ([0.760]; 0.623 – 
0.927) 
Month 6  Nothing significant 
Month 9  Decreased overall TPs M12 
([0.509]; 0.292 – 0.887) 
Month 12  Nothing significant 
Month 15  Increased teething fever 


















Decreased teething pain M15 ([0.933]; 
0.880 – 0.989) 
Decreased teething fever M15 ([0.894]; 
0.823 – 0.971) 
Decreased overall TPs M15 ([0.687]; 




Non – tertiary* 
Increased teething fever M9 ([1.146]; 
1.041 – 1.261) 
Decreased teething fever M15 ([0.888]; 







*, Reference group; shaded portion represents positive findings 
 
According to the findings in Table 4-8, potential confounders such as mother 
age, child factors (systemic fever, diarrhea and antibiotics), mode of delivery 
(C-section) and education level (non-tertiary) seems to reduce the incidence of 
TPs. 
 
4.6 Summary of results 
4.6.1 Type of probiotics 
 
Different types of probiotic sources were included in the present study. Since, 
different source of probiotics have different species and accounts for different 
effect on outcome. Hence, they were analyzed separately and also the 
interaction among them were considered. Infant formula milk with 
prebiotics/probiotics has shown positive association with TPs at 15 month when 
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taken at 3 week or 9 month. In a nut shell, different types of probiotics has 
shown varied effect on TPs. Summary results of different type of probiotics on 
TPs is shown in Table 4-9. 
 
Table 4-9 Effect of different type of probiotics on TPs 
 
4.6.2 Timing of probiotics 
 
In the present study, information about maternal and infant probiotics intake 
was taken at different. Therefore, it was a great opportunity to study the window 
effect of exposure on outcome. According to present findings it has been 
observed effect of probiotics is time dependent as listed below: 
 Maternal probiotics intake one month before delivery and confinement 
has shown positive association with TPs.  
 Formula milk with prebiotics have shown positive association with 15 
M outcome if taken during 9 M or week 3.  
 Formula milk with synbiotics have shown positive effect at 15 month 
outcome if taken at 9 month. 
 Formula milk with probiotics have shown beneficial effect if taken only 
at 9 M or week 3. 
To summarize, Infant intake of probiotics at 9 month and 3 week seems to be 




Type of probiotics Effect 
1) Vitagen® Negative association 
2) Yakult® Nothing significant association 
3) Yoghurt Negative association 
4)      Supplements Nothing significant association 
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4.6.3 Effect of probiotics on outcome 
 
There are 4 major teething problems included in the present study. Teething is 
a physiological process and is accompanied with different teething signs and 
symptoms. Sign is considered to be objective whereas symptoms are quite 
subjective which may vary from subject to subject. Moreover, all signs and 
symptoms occurring during teething has different physiology. The effect of 
probiotics on TPs is as shown below: 
 The positive association observed are basically on teething pain, 






















Based on the extensive search on databases including Pubmed, Scopus, Web of 
Science, and Lancet, this is the first large prospective cohort which analyzes the 
effect of probiotics on teething problems. “Teething symptoms have been 
poorly understood despite many commendable efforts over the past 10 years to 
address them (Wake et al. 1999, 2000; Macknin et al. 2000; Barlow et al. 2002; 
Wake & Hesketh 2002; Peretz et al. 2003; Baykan et al. 2004; Cunha et al. 
2004; Sarrell et al. 2005; Tighe & Roe 2007; Feldens et al. 2010; Mota-Costa 
et al. 2010; Owais et al. 2010). Although teething is a physiological process, its 
symptoms are distressing and yet so neglected” (Plutzer et al., 2012). 
The findings of this study have shown an association between maternal/infants’ 
probiotics intake and the incidence of teething problems. Due to the multiethnic 
nature of the GUSTO cohort,  it was a great opportunity to assess the impact of  
races with various potential confounding variables like maternal/infants 
probiotics intake, maternal age, race, mother education, household income, 
infant’s gender, mother/child health status, mother smoking status during 
pregnancy, breastfeeding practice and mode of delivery. The maternal nutrition 
is primarily responsible for fetal growth and also linked to children’s risk to 
diseases later in life (Lucas, 1998) which  formed the basis of hypothesis in the 
present study. Furthermore, since the data was collected at various time points 
it was indeed a good platform to study the window period of exposure 
(probiotics) on outcome (TPs). 
 
During analysis, different models were constructed to avoid type I and type II 
error. Initially, enter model was done followed by stepwise and finally the 
consistent results of enter and step wise model were reported.  
5.1 Teething Problems 
 
In the present study, there are five outcomes which constitute the TPs, namely 
teething pain, teething fever, decreased food intake, decreased daily activity and 
overall TPs. Since GUSTO cohort questionnaire includes information from 
various domains the distinctions between the systemic and teething related 
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signs/symptoms four major TPs were made through in oral health questionnaire 
administered by trained home visitors. Among the five outcomes, teething fever 
is considered as an objective sign  
It has been observed from present findings that infants experienced more TPs 
within 15 – 18 months (54.40%) period in comparison to other time points; 18 
months of age is characterized by multiple tooth eruption stage which may 
establish a stress condition, during which the resistance against infections may 
be reduced and incidence of infectious diseases increased (Bennett and Brudno, 
1986; Carpenter, 1978). Wake et al. (2000), investigated the relationship 
between tooth eruption, fever and teething symptoms in Australia and suggested 
that, though parents frequently reported multiple symptoms (Table 5-1), 
occurred during the tooth eruption, significant strong association between tooth 
eruption and range of teething symptoms was not confirmed in children 6 to 30 
months old.  
Table 5-1 Symptoms suffered resulting from teething: beliefs of parents 
 
Adapted from Wake et al. (2000) 
Symptom % of Study Parents Reporting 
Pain 67 
Irritability 71 
Sleep disturbance 71 
Drooling/dribbling 57 
Red cheeks 76 
Fever 48 
Diaper rash 52 
Sooky clingy 52 
Runny nose 43 
Loose stools 33 
Smelly urine 33 




On the contrary,Feldens et al. (2010), described a high occurrence of teething 
symptoms in a cohort conducted in Brazil including 500 children recruited at 
birth. Clinical examinations were carried out at 6 months and one – year of age. 
Teething symptoms were reported in 73% of children.  
Similarly, Kiran et al. (2011) reported gingival irritation (95.9%) to be the most 
common finding in Indian population. In the present study, Indians residing in 
Singapore showed less teething symptom as compared to Chinese and Malays. 
Further studies should be done to explain the difference between the incidence 
of TPs with regards to ethnicity. 
 
5.2 Maternal/Infant probiotics intake 
5.2.1 Maternal probiotics intake 
 
In the present study it has been observed that maternal probiotics intake has 
negative association on the incidence of teething problems. The main sources 
of probiotics are Vitagen®, Yakult®, yoghurt and yoghurt drink. 
Currently there is insufficient evidence regarding the strain specific randomized 
control trials and their administration to pregnant mothers. More studies are 
required to distill clinical recommendations on the usage of probiotics. 
 
5.2.2 Infant probiotics intake 
 
To study the data effectively and analyze the association between probiotics and 
TPs, infant formula milk was divided into prebiotics, probiotics or synbiotics 
(PPS) according to the ingredients of brands consumed by them. Infant formula 
milk with PPS at the 9 month time point has shown beneficial effect on TPs at 
15 month. Interestingly, positive effect of probiotics was observed on teething 
pain at M15. The most possible reason for this may be that 15 month outcome 
means TPs between 12 -15 month and until 12 months most of the babies have 
their first tooth erupted to give better clarity of teething problems to mothers. 
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Also, Infant formula milk with PPS has shown negative association teething 
related decrease activity in infants. These findings are in relation with earlier 
studies done to analyze the association of PPS added in formula milk with 
various outcome. Chouraqui et al. (2008), found no difference in diarrhea and 
weight gain between infants fed with control formula with or study formula 
group (probiotics and synbiotics). Furthermore,Weizman and Alsheikh (2006) 
has shown no significant differences between growth parameters, crying and 
irritability among infants between different groups (standard milk-based 
formula supplemented with either Bifidobacterium lactis (BB-12), 
Lactobacillus reuteri (ATCC 55730) or a probiotics-free formula).  
Strikingly, findings of present study also indicates the negative association of 
probiotics on TPs. There are some of the detrimental effects which has been 
observed on teething fever, decreased food intake and overall TPs at some time 
points. One of the most speculated reason for these findings may be dose of 
probiotics, prebiotics and synbiotics in formula milk. In the present study, it was 
very difficult to quantify the dosage of formula milk consumed by infants per 
day which is one of the limitation as well. Unfavorable and detrimental effect 
of probiotics are also seen in one of the retrospective study in which 
lactobacillus GG failed to reduce the incidence of necrotizing enter colitis in 
very-low-birth-weight babies (Luoto et al., 2010).“Such an observation raises 
concern that other long – term effects, such as immunosuppression, may also 
occur in later life” (Szajewska, 2011). Table 5-4, clearly indicates the arguments 
against and in favor of probiotics which may be responsible for inconsistent 









Table 5-2 Arguments for and against pooling data on different probiotics 
Arguments for Arguments against 
Allows one to:  
 Increase sample size and power 
 Establish whether there is evidence of 
an effect 
 Determine the direction/size of the 
effect and 95% CI 
 Assess the consistency of the effect 
across studies 
 Identify the most promising probiotics 
and decide whether further research on 
these probiotics is substantiated  
 Probiotic supplementation is not a 
homogeneous intervention 
 Pooling data from different genera, 
species, strains, and doses of probiotics 
obtained in different population, 
presumably with variations in their 
native intestinal microbiota, may result 
in misleading conclusions 
 The risk is that the results could be 
erroneously extrapolated to other 
probiotics or other patient groups 
Adapted from (Szajewska, 2011) 
Furthermore, hardly any evidence in literature is available for the interaction of 
probiotics with different types of diet consumed by various ethnic groups. 
Though there have been many studies done and ongoing related to 
administration of probiotics during early life in order to reduce the risk of 
various health manifestations but still there are many questions than answers. 
More studies should be done to confirm the efficacy and safety of probiotics in 
pediatric population.  
5.3 Confounders 
5.3.1 Child factors 
5.3.1.1 Gender 
 
Gender has shown no significant association with TPs. In contrast, Noor-
Mohammed and Basha (2012) showed that boys has a higher prevalence of 
diarrhea than girls during tooth eruption.  
 
5.3.1.2 Child health 
 
Child health factors have shown association with TPs. Infants who had systemic 
fever (non-teething fever) were significantly associated with increased 
incidence of TPs whereas infants who had antibiotics reported less incidence of 
TPs up to M1. Findings of the present study are in agreement with Macknin et 
al. (2000) who reported that teething is accompanied with decreased food 
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intake, abnormal rise in temperature, irritability which can account for 
decreased daily activity and wakefulness. Rise up to 0·6°C in body temperature 
has also been demonstrated during the teething process by Jaber et al. (1992). 
Since, in the present study the data was collected at particular time points 
therefore, it is difficult to estimate the specific rise in temperature and other 
symptoms during tooth eruption for that time instance.  
 
5.3.2 Maternal factors 
5.3.2.1 Breastfeeding practice 
 
Significant association was observed between breastfeeding practice and 
teething problems. Mothers who breastfed month 3 and month 9, their infants 
had less incidence of teething pain and teething fever. Interestingly, trends have 
been observed that beneficial effect of month 3 breastfeeding is on month 15 
outcome whereas effect of month 9 breastfeeding is on month 12 outcome. 
Since, the information about maternal probiotics intake was not taken after 
confinement it is difficult to confirm that whether it is the sole effect of 
breastfeeding practice or combined effect of breastfeeding and maternal 
probiotics intake.  
Furthermore, breastfeeding has shown negative association with teething 
related decreased food intake and decreased activity. But, decreased food intake 
and decreased activity are subjective and depends on mother’s personal 
perception compared to teething fever which is a sign. Moreover, in present 
study the frequency and type of breastfeeding was not taken into consideration 
which may hold for these findings.  
 
5.3.2.2 Household income 
 
Household income (≥ 4,000S$) showed no significant association with the 
incidence of TPs. These findings are contradictory with the study done by 
Feldens et al., 2010, who found the risk of reporting teething symptoms is 
higher with higher income population. The possible reason for this finding may 
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be that in GUSTO cohort, mothers’ are educated and depending on present 
scenario about belief of TPs they believe that teething is a natural process and 
may not be accompanied by serious consequences. 
 
5.3.2.3 Mother race 
 
Mother race was significantly associated with the incidence of TPs. Chinese and 
Malay reported more of TPs compared to Indians. One of the possible 
speculation for this finding is that Chinese teeth erupt early as compared to 
Indians. Further studies should be done to evaluate comparison between 
different races with the incidence of TPs. 
 
5.3.2.4 Mode of delivery 
 
Interestingly, infants who were delivered through C-section has shown less 
incidence of TPs compared to those who were delivered by normal vaginal 
delivery. In contrast, Merenstein et al. (2011), found that infants delivered by 
C- section experienced had significantly higher rates of cumulative infectious 
diseases, lower respiratory tract infections and cough. More studies should be 
done to explore the effect of normal and c – section delivery on the general 
health of children. 
 
5.3.2.5 Mother age 
 
With one unit increase in age has shown to slightly reduce the incidence of some 
teething problems but increase the incidence of decreased food intake (Table 4-
10). Since, there is no evidence in literature regarding mother age and TPs, we 






5.3.2.6 Mother education 
 
In the present study, it has been observed that maternal education plays an 
important role in reporting the incidence of TPs. Mothers’ with tertiary 
education reported more/less of TPs at different timing as compared to mothers 
with non-tertiary education (primary or secondary). This may be due to the 
learning experience reporting less TPs at M15 versus M9. There can be 2 
reasons for these findings, either higher educated mothers understand the 
physiology of tooth eruption and do not report the symptoms as a problem at 
M15 or because they are more conscious about or sensitive to the activities of 
their kids at M9 and report more symptom during that time. 
Mother long-term illness and smoking status during pregnancy has shown no 




Before the start of baseline data collection, a qualified team was formed and 
examiners were trained. The criteria and procedures were thoroughly discussed 
and all the examiners (trained nurses / home visitors) were calibrated with the 
standard examiner. Internal validity of the study was ensured by periodic 
calibration sessions of home visitors by research coordinator. 
5.4 Limitations/Methodological issues and data analysis  
 
It was very hard to accurately quantify the dosage of formula milk and 
supplements consumed by infants at each time point. 
Also, information about maternal probiotics intake after confinement was not 
collected. At present, the infants who did not take probiotics is in reference 
group but some of them might receive the probiotic effect from maternal intake 
after confinement through breastfeeding. Therefore, this potential confounding 
factor may dilute the effect of probiotics. 
Different data analysis approaches were incorporated to increase the accuracy 
and consistency. In the logistic regression all interactions among maternal and 
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infant probiotics sources of probiotics, between maternal and infant till 6 
months to infants’ age and all confounders were incorporated, but OR and 95% 
CI for infants probiotics intake were unexpectedly high. The next approach was 
the Poisson regression considering calculating RR instead of OR. Poisson 
regression provided narrower 95% CI, later enter model findings were 
compared with Poisson Regression findings. Based on the results from both 
regression, the major trends were identified when both the data analysis 
confirmed same significant results. As mentioned above, our design is not 
typical or ideal to generate OR or RR.  
With regards to validity of the study, internal validity was ensured but further 
studies should be done taking into account the dosage of probiotic sources to 

















6 Conclusion and Further Studies 
6.1 Conclusion 
 
According to the data of the present study timing and type of probiotic intake 
play an important role on the effect of probiotics. The physiology of different 
teething sign/symptoms varies therefore, the effect of probiotics may also differ 
with relation to various symptoms occurring during the different eruption 
periods of primary teeth. It is clear that not all the types of probiotics will reduce 
the TPs. 
6.2 Further studies 
 
Since this is a pioneer study to analyze the association between probiotics and 
TPs. Based on the current findings, the following future studies may be 
conducted: 
1. Randomized control trial (RCT): To evaluate the dose standards and 
safety/efficacy of single- and multi-strain strain probiotics. 
2. There should be well administered questionnaire with regards to 
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1. Maternal probiotics intake 
 
A. Before Pregnancy 





B. One month before delivery 
 During the month just before you gave birth, how often did you eat the following foods: 
(Please enter quantity and indicate either per day or per week)? Enter 0 if do not consume 
or consume less than 1 per week). 
b1) Yoghurt ---------pots per          day           week 
 
b2)  Vitagen®  ----------bottles per        day           week 
 
b3)   Yakult® ………….bottles per          day           week 
 
b4) Other yoghurt drinks -------- glass (200 ml) per              day            week 
 
 
 Did you take any other food or powder or supplement containing probiotics (good 
bacteria)? 
0. No 
1. Yes, Please specify type and dosage. 
 
C. During confinement 
 How often do you eat the following foods: 
c1) Yoghurt ---------pots per            day             week 
 
c2)  Vitagen®  ----------bottles per          day           week 
 
c3)   Yakult® …………. bottles per          day           week 
 
c4) Other yoghurt drinks -------- glass (200 ml) per             day            week 
 
 Did you take any other food or powder or supplement containing probiotics (good 
bacteria)? 
0. No 
















2. Infant probiotics intake 
 
 Does your baby take any powder/drops/supplement/medicine containing probiotics 
(good bacteria)?  
             0. No 
             1. Yes 
Supplements--------- 
Total daily dose and unit ---------- 
Age started—mths / wks / days 
Age stopped---- mths / wks / days 
Date started (dd/mm/yy) 
Date stopped (dd/mm/yy) 
 
 Has your child started eating the following foods (yoghurt)? (asked 9 – 12 mths) 
 
 Which types of formula milk or formula have your baby used? What age was your baby 
when it was started and stopped or on what date it was started and stopped. Please write 
down all formula used previously, including the one that the baby is currently using? (3 
weeks until 18 months) 
Formula code------------- 
Age started—mths / wks / Days 
Age stopped---- mths / wks / days 
Date started (dd/mm/yy) 
Date stopped (dd/mm/yy) 
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 ENTER Model  
OR (95% CI) 
Teething pain M6 
Vitagen®  pregnancy 1.030 (1.002 - 
1.059) NS 
Teething fever M6 
Infant FM M3 with probiotics: 
0.118 (0.015 - 0.957) 
NS 





problem M 6 
NS NS 
Teething pain M9 
Child supplement M9 
3.049 (1.058 - 8.849) 
Had teething pain M6 4.704 
(1.016 - 21.780) 
Teething fever M9 
Infant FM M6 with prebiotics: 
0.469 (0.262 - 0.840) 
Infant FM M6 with pre & pro: 2.059 
(1.041 - 4.072) 
Mother age 0.913 (0.839 - 
0.993) 
Tertiary education 0.207 
(0.068 - 0.630) 
Decreased food M9 
Infant FM M9 with pro: 2.730 
(1.263 -  5.900) 
 
Yogurt pregnancy : 1.101 
(1.020,  1.188) 
Mother age 0.886 (0.811 - 
0.967) 






problem M 9 
NS  
Chinese 4.314 (1.352 - 
13.761) 
Teething pain M12 
Yogurt pregnancy 1.022 (1.005 -  
1.040) 
Child supplement M3 




Infant FM M6 with pre: 2.163 
(1.050 - 4.456) 
Child supplement M9 
4.098 (1.497 - 11.236) 
Child supplement M12 3.546 (1.560 
- 8.065) 
Teething fever M12 NS 
Had Diarrhea M9 5.419 (1.152 
- 25.491) 
Had BF M9 0.014 (0.000 - 
0.575) 
formula milk M6 prebiotics 
56.241 (4.669 - 677.468) 
formula milk M6 probiotics 
141.064 (3.737 - 5325.142) 
formula milk M6 pre & 
probiotics 23.204 (1.963 - 
274.347) 
Yogurt M9 0.167 (0.031 - 
0.909) 
Had teething fever M6 8.453 
(1.145 - 62.403) 
Had teething fever M9 35.347 
(9.337 - 133.806) 
Decreased food 
M12 
Infant FM M3 with probiotics 2.333 
(1.226 - 4.441) 
Infant FM M3 with pre & probiotics 
2.302 (1.246 - 4.255) 
Infant FM M6 with probiotics 2.478 
(1.265 - 4.851) 
Infant FM M6 with pre & probiotics 
1.999 (1.114 - 3.585) 
Infant FM M9 with probiotics 2.167 
(1.134 -4.141) 
Mother age .878 (.794 - .971) 
Formula milk M9 with 
probiotics 11.359 (1.119 - 
115.293) 




Infant FM M12 with probiotics 
1.882 (1.009 -3.508) 
Decreased activity 
M12 
Infant FM M9 with pre & probiotics 






Child supplement M12  
8.065 (1.122, 6.135) 
 
Mother age 0.899 (0.829 - 
0.974) 
Had antibiotics M9 0.267 
(0.080 - 0.893) 
Formula milk M6 prebiotics 
13.371 (2.165 -  82.571) 
Formula milk M6 pre& 
probiotics 10.746 (1.733 - 
66.618) 
Had yogurt M9: 0.265 (0.077- 
0.918) 
Had any teething problem M9 
5.873 (2.521 - 13.684) 
Teething pain M15 
Infant FM M15 with pre & 
probiotics 0.469 (0.239 - 0.921) 
 
C – section mode of delivery 
0.153 (0.027 – 0.873) 
Formula milk week3 
prebiotics 0.099 (0.012 - 
0.809) 
Formula milk M3 pre & 
probiotics 43.034 (2.087 - 
887.505) 
Formula milk M9 prebiotics 
0.017 (0.000467 - 0.591) 
Formula milk M9 pre & 
probiotics 0.006 (0.000 - 
0.350) 
Had teething pain M9 13.553 
(2.409 - 76.252) 
Teething fever M15 
Yogurt pregnancy   
0.76 (0.955 - 0.998) 
Malay 6.800 (1.395 - 33.147) 
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Infant FM M12 with pre & 
probiotics 0.552 (0.327 - 0.933) 
Infant FM M15 with pre & 
probiotics 0.541 (0.308 - 0.952) 
Tertiary education 3.466 
(1.208 - 9.943) 
C – section mode of delivery 
0.178 (0.056 - 0.571) 
Had fever M3 5.228 (1.182 - 
23.132) 
Had antibiotics M3 0.035 
(0.002 - 0.562) 
Had breastfeeding M3 0.144 
(0.038 - 0.555) 
Yogurt pregnancy 1.113 
(1.007- 1.230) 
Yogurt confinement 0.743 
(0.570 - 0.970) 
Had teething fever M9 4.296 
(1.362 - 13.548 ) 
Had teething fever M12 7.043 
(2.343 - 21.168) 
Decreased food 
M15 
Infant FM week3 with probiotics 
2.346 (1.228 -4.482) 
 
Mother age 1.108 (1.018 - 
1.207) 
Chinese 7.214 (1.349 - 38.580 
) 
HH income ≥ 4, 000 S$ 0.350 
(0.133 - 0.925) 
Had BF week 3 5.776 (1.057 - 
31.557) 
Had fever M3 5.178 (1.215 - 
22.072) 
Had diarrhea M6 12.365 
(1.264 - 120.958) 
Had BF M6 0.132 (0.021 - 
0.823) 
Formula milk M9 probiotics 
0.006 (0.00114 - 0.239) 
Formula milk M9 pre & 




Formula milk M12 probiotics 
46.602 (1.063 - 2042.576) 
Yogurt M9 5.455 (1.178 - 
25.268) 
Yogurt M12 0.351 (0.125 - 
0.986) 
Had decreased food M9 3.245 
(1.093 - 9.637) 
Had decreased food M12 
11.922 (4.280 - 33.210)  
Decreased activity 
M15 
Infant FM M3 with prebiotics 0.466 
(0.219 - 0.991) 
Infant FM M12 with pre & 
probiotics 0.319 (0.132 - 0.774) 
Child supplement M9  
9.009 (3.155, 25.641) 
Child supplement M12 
3.0488 (1.010, 9.259) 
Nothing  
Any teething 
problem M 15 
Infant FM M9 with pre & probiotics 
0.562 (0.347 - 0.908) 
Infant FM M15 with pre & 
probiotics 0.570 (0.342 - 0.951) 
Had long term illness 9.355 
(1.340 - 65.297) 
C – section mode of delivery 
0.321 (0.128 - 0.808) 
Had fever M3 6.575 (1.641 - 
26.342) 
Had antibiotics M3 0.092 
(0.012 - 0.737) 
Had breastfeeding M3 0.350 
(0.130 - 0.945) 
Had fever M9 2.663 (1.115 - 
6.361) 
Had fever M12 0.334 (0.118 - 
0.942) 
Formula milk week3 pre & 




Formula milk M3 pre & 
probiotics 24.265 (3.653 - 
161.170) 
Formula milk M9 probiotics 
0.027 (0.001 - 0.504) 
Formula milk M9 pre & 
probiotics 0.040 (0.004 - 
0.414) 
Yogurt M12 0.329 (0.126, 
0.854) 
Any teething problem M9 
3.272 (1.288 - 8.310) 
Any teething problem M12 
9.032 (3.548 - 22.990) 
Teething pain M18 
Child supplement M18  
 
3.984 (1.033 - 3.984) 
Chinese 57.028 (2.796 - 
1163.311) 
 
Malay 29.496 (1.206 - 
721.319) 
Had diarrhea M15 .122 (.019 - 
.798) 
Yakult®   confinement 1.225 
(1.027 - 1.462) 
Had teething pain M12 12.252 
(2.146 - 69.944) 
Had teething pain M15 13.162 
(1.610 - 107.626) 
Teething fever M18 
Infant FM week3 with probiotics 
1.918 (1.002 - 3.672) 
Infant FM M18 with probiotics 
2.301 (1.118 - 4.736) 
Malay 23.758 (1.686 - 
334.703) 
Had fever M3 0.093 (0.009 - 
0.926) 
Had fever M9 5.013 (1.321 - 
19.016) 
Had diarrhea M15 0.139 
(0.024 - 0.807) 
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Had antibiotics M15 6.603 
(1.601 - 27.225) 
Had breastfeeding M15 0.001 
(0.000 - 0.582)  
Yogurt pregnancy 1.144 
(1.005 - 1.302) 
Vitagen®   pregnancy 1.318 
(1.020 - 1.703) 
Yogurt confinement 0.682 
(0.483 - 0.963) 
Formula milk week3 
probiotics 314.201 (11.619 - 
8496.735) 
Formula milk M12 probiotics 
850.754 (1.308 - 553379.41) 
Decreased food 
M18 
Probiotics supplement during 
confinement  
13.550 (1.087 - 108.835) 
Infant FM week3 with prebiotics 
1.936 (1.164 - 3.219) 
Infant FM week3 with probiotics 
2.333 (1.252 - 4.349) 
Infant FM week3 with pre & 
probiotics 2.070 (1.181 - 3.626) 
Infant FM M3 with prebiotics 1.666 
(1.052 - 2.640) 
Infant FM M3 with pre & probiotics 
2.446 (1.427 - 4.193) 
Infant FM M6 with pre & probiotics 
1.651 (1.002 - 2.721) 
Infant FM M15 with prebiotics 
2.323 (1.273 - 4.239) 
Infant FM M15 with pre & 
probiotics 2.006 (1.101 - 3.654) 
Infant FM M18 with prebiotics 
2.152 (1.185 - 3.911) 
C – section mode of delivery 
0.205 (0.051 - 0.816) 
 
Had diarrhea M12 0.128 
(0.023 - 0.723) 
 
Vitagen®   pregnancy 1.210 
(1.014 - 1.443) 
Formula milk week 3 
prebiotics 95.315 (5.372, 
1691.081) 
Formula milk week 3 
probiotics 140.693 (4.461, 
4436.926) 
Formula milk week 3 pre & 
probiotics 34.025 (2.208, 
524.274) 
Had decreased food M12 
8.613 (2.189 - 33.883) 
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Infant FM M18 with probiotics 
2.633 (1.300 - 5.334) 
Infant FM M18 with pre & 
probiotics 2.008 (1.103 - 3.654) 
Decreased activity 
M18 
Nothing  Nothing  
Any teething 
problem M 18 
Infant FM M15 with prebiotics 
1.950 (1.147 -3.318) 
Infant FM M18 with prebiotics 
1.845 ( 1.092 - 3.117) 
Infant FM M18 with probiotics 
2.420 (1.261 - 4.642) 
Yogurt pregnancy 1.154 
(1.020 - 1.306) 
Yogurt confinement  0.821 
(0.675 - 0.999) 
Had diarrhea M12 0.108 
(0.020 - 0.579) 
Had any teething problem 
M15 3.692 (1.167 - 11.682) 
 





























Table 8-4 Comparison summary of enter model (logistic regression) and poisson 
regression 

























Decreased food intake M9 
([1.101] 1.020 – 1.188) 
Decreased food intake M9 ([1.009] 1.002 
- 1.017) 
Teething fever M15 
([1.113] 1.007 – 1.230) 
 
Teething fever M18 
([1.144] 1.005 – 1.302) 
Overall TPs M18 ([1.154] 
1.020 – 1.306) 
 Decreased food intake M6 ([1.160] 1.116 
- 1.205) 
Overall TPs M9 ([1.030] 1.005 - 1.055) 
Teething pain M12 ([1.016] 1.007 - 1.025) 
Teething pain M15 ([1.009] 1.002 - 1.016) 
During 
confinement  
Teething fever M15 
([0.743] 0.570 – 0.970) 
 
Teething fever M18 
([0.682] 0.483 – 0.963) 
Overall TPs M18 ([0.821] 
0.675 – 0.999) 
Overall TPs M18 ([1.564] 1.165 - 2.098) 









Nothing significant Teething fever M6 ([1.148] 1.077 - 1.224) 
Decreased food intake M12 ([1.010] 1.001 
- 1.018) 
Decreased activity M15 ([1.010] 1.005 - 
1.016) 
Overall TPs M15 ([1.047] 1.006 - 1.089) 






Teething fever M18 ([0.985] 0.975 - 
0.995) 
Decreased food intake M18 ([0.984 (0.973 
- 0.995) 











Teething fever M18 
([1.318] 1.020 – 1.703) 
 
 
Teething fever M18 ([1.018] 1.006 - 
1.031) 
Decreased food intake M18 
([1.210] 1.014 – 1.443) 
 







Nothing significant Decreased activity M6 ([1.126E-009] 
2.852E-012 - 4.609E-007) 
Teething fever M12 ([1.019] 1.009 - 
1.028) 
Overall TPs M12 ([1.065] 1.024 - 1.107) 
Decreased food intake M18 ([0.947] 0.913 
- 0.983) 
Maternal 







Nothing significant Nothing significant 
During 
confinement  
Teething pain M18 
([1.225] 1.027 – 1.462) 
 
Decreased food intake M6 ([2.611E-009] 
1.452E-011- 4.725E-007) 
Decreased activity M6 ([1.140E-008] 
2.187E-009 - 5.939E-008) 
Teething fever M9 ([0.995] 0.991 - .9997) 
Teething fever M12 ([1.015] 1.006 - 
1.024) 














Nothing significant Teething fever M6 ([3.458] 2.430 – 4.922) 
Teething fever M9 ([1.962] 1.537 - 2.505) 
Overall TPs M9 ([484788587.801] 
50890881.307 - 4618115639.282) 
Teething fever M12 ([1.739] 1.249 - 
2.422) 
Decreased food intake M12 ([2.429] 1.773 
- 3.328) 
Decreased activity M12 ([1.969] 1.703 - 
2.277) 
Overall TPs M12 ([15658112.846] 
1462803.941 - 167607217.225) 
Teething pain M15 ([2.415] 1.744 - 3.343) 
Teething fever M15 ([0.636] 0.409 - 
0.990) 
Overall TPs M15 ([116550226.299] 0.000 
- 0.000) 
Teething pain M18 ([3.585] 1.696 - 7.582) 




Nothing significant Teething fever M9 ([0.804] 0.672 - 0.961) 
Overall TPs M9 ([8.581E-009] 1.012E-
009 - 7.279E-008) 
Overall TPs M12 ([4.654E-007] 5.620E-
008 - 3.854E-006) 
Overall TPs M15 ([2.141E-008] 3.436E-
010 - 1.334E-006) 
Teething fever M18 ([1.884] 1.394 - 
2.547) 
Decreased food intake M18 ([1.794] 1.274 
- 2.526) 
 3 week  Teething pain M15 
([0.099] 0.012 – 0.809) 














Decreased food M18 




Decreased food intake M18 ([1.413] 1.175 
- 1.699) 
 Teething fever M18 ([1.218] 1.012 - 
1.465) 
3 Month Nothing significant Teething pain M12 ([0.813] 0.700 - 0.945) 
Overall TPs M12 ([0.482] 0.261 - 0.891) 
6 month  Teething fever M12 
([56.241] 4.669 – 677.468) 
Teething fever M12 ([1.294] 1.079 - 
1.552) 
 Teething pain M12 ([1.250] 1.058 - 1.477) 
Decreased food intake M15 ([0.859] 0.759 
- 0.973) 
Overall TPs M12 ([13.371] 
2.165 – 82.571) 
Overall TPs M12 ([3.642] 1.549 - 8.564) 
9 month  Teething pain M15 
([0.017] 0.000467 - 0.591) 
Teething pain M15 ([0.760] 0.664 - 0.870) 
 Decreased food intake M15 ([0.822] 0.700 
- 0.965) 
Overall TPs M15 ([0.459 0.242 - 0.868) 
12 month  Nothing significant Teething fever M18 ([1.376] 1.031 - 
1.836) 







3 week  Teething fever M18 
([314.201] 11.619 - 
8496.735) 
Teething fever M18 ([1.445] 1.091 - 
1.913) 
Decreased food intake M18 
([140.693] 4.461 - 
4436.926) 
Decreased food intake M18 ([1.448] 1.115 
- 1.881) 
 Teething pain M12 ([0.825] 0.689 - 0.987) 




6 month Teething fever M12 
([141.064] 3.737 - 
5325.142) 
Teething fever M12 ([1.464] 1.090 - 
1.966) 
 Teething fever M9 ([0.814] 0.663 - 0.999) 
Overall TPs M12 ([3.888] 1.452 - 10.414) 
Decreased activity M9 ([0.915] 0.839 - 
0.998) 




Decreased food intake M12 
([11.359] 1.119 - 115.293) 
 
Decreased food intake M15 
([0.006] 0.00114 - 0.239) 
Decreased food intake M15 ([0.592] 0.466 
- 0.753) 
Overall TPs M15 ([0.027] 
0.001 - 0.504) 
Overall TPs M15 ([0.203] 0.053 - 0.780) 
 Teething pain M15 ([0.880] 0.678 - 1.141) 
12 month  Decreased food intake M15 
([46.602] 1.063 - 
2042.576) 
Decreased food intake M15 ([1.552] 1.182 
- 2.038) 
Teething fever M18 
([850.754] 1.308 - 
553379.41) 
Teething fever M18 ([1.707] 1.107- 
2.633) 
 Teething pain M18 ([1.811] 1.069 - 3.069) 














3 week Overall TPs M15 ([0.082] 
0.013 - 0.501) 
Overall TPs M15 ([0.467] 0.255 - 0.857) 
Decreased food intake M18 
([34.025] 2.208 - 524.274) 
Decreased food intake M18 ([1.296] 1.048 
- 1.603) 
 Decreased activity M12 ([0.903] 0.825 - 
0.988) 
3 month Teething pain M15 
([43.034] 2.087 - 887.505) 
Teething pain M15 ([1.275] 1.125 - 1.446) 
Overall TPs M15 ([24.265] 
3.653 - 161.170) 
Overall TPs M15 ([3.189] 1.677- 6.063) 
 Teething fever M15 ([1.193] 1.028 - 
1.384) 





Teething pain M12 ([0.834] 0.718 - 0.970) 
Overall TPs M12 ([0.481] 0.245 - 0.946) 
6 month  Teething fever M12 
([23.204] 1.963 - 274.347) 
Teething fever M12 1.210 (1.010 - 1.451) 
Overall TPs M12 ([10.746] 
1.733 - 66.618) 
Overall TPs M12 ([3.278] 1.388 - 7.742) 
 Decreased food intake M9 ([1.153] 1.003 
- 1.325 ) 
Teething pain M12 ([1.320] 1.131 - 1.539) 
9 month  Teething pain M15 
([0.006] 0.000 - 0.350) 
Teething pain M15 ([0.721] 0.595 - 0.873) 
 Decreased food intake M15 ([0.725] 0.590 
- 0.892) 
Overall TPs M15 ([0.197] 0.079 - 0.489) 
12 month Nothing significant Nothing significant 





9 month  Teething fever M12 
([0.167] 0.031 – 0.909) 
 
Decreased food intake M12 
([0.182] 0.037 – 0.903) 
Overall TPs M12 ([0.265] 
0.077 – 0.918) 
Decreased food intake M15 
([5.455] 1.178 – 25.268) 
 Teething fever M15 ([0.711] 0.530 - 
0.954) 
Decreased activity M18 ([2.533] 1.106 - 
5.801) 
12 month Decreased food intake M15 
([0.351] 0.125 – 0.986) 
 
Overall TPs M15 ([0.329] 
0.126 – 0.854) 
 Teething pain M18 ([1.603] 1.104 - 2.328) 
92 
 
Decreased food intake M18 ([1.467] 1.034 
- 2.083) 








3 week Nothing significant Teething pain M9 ([1.898] 1.379- 2.614) 
 
Overall TPs M9 ([108042980.681] 
9690343.058 - 1204630796.255) 
Teething pain M15 ([0.586] 0.376 - 0.914) 
Decreased activity M15 ([0.659] 0.438 - 
0.994) 
Overall TPs M15 ([0.337] 0.000 - 0.000) 
Teething pain M18 ([0.304] 0.156 - 0.593) 
3 month Nothing significant Overall TPs M9 ([1.357E-008] 8.270E-
010 - 2.227E-007) 
Decreased food intake M6 ([0.461] 0.359 
- 0.594) 
Teething pain M15 ([0.824] 0.700 - 0.971) 
Teething fever M18 ([1.430] 1.094 - 
1.871) 
Decreased food intake M18 ([1.404] 1.065 
- 1.851) 
Overall TPs M18 ([2.583] 1.189 - 5.608) 
6 month Nothing significant Decreased food intake M9 ([0.800] 0.686 
- 0.933) 
Overall TPs M9 ([1.809E-008] 2.223E-
009 - 1.473E-007) 
Decreased food intake M12 ([0.727] 0.589 
- 0.896) 
Overall TPs M15 ([5.904E-009] 0.000 - 
0.000) 
Teething pain M18 ([2.558] 1.371 - 4.775) 
9 month Nothing significant Teething pain M15 ([0.281] 0.148 - 0.533) 















Decreased activity M18 ([3.334] 1.554 - 
7.151) 
Overall TPs M18 ([2.473E-009] 8.372E-
011 - 7.310E-008) 
12 month Nothing significant Teething fever M18 ([0.381] 0.160 - 
0.908) 
Decreased activity M18 ([0.297] 0.160 - 
0.549) 
Overall TPs M18 ([0.039] 0.002 - 0.872) 
15 month Nothing significant Teething fever M18 ([0.615] 0.394 - 
0.961) 
